1![](https://www.pdfsearch.io/img/40d1da1171e70e4add5111d047be17fd.jpg) | Add to Reading ListSource URL: erialcl.netLanguage: English - Date: 2015-10-05 11:40:28
|
---|
2![Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016 Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016](https://www.pdfsearch.io/img/568e558be7ae08c3016e116852dc960b.jpg) | Add to Reading ListSource URL: alkatras.erialcl.netLanguage: English - Date: 2016-04-15 08:51:39
|
---|
3![Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev](https://www.pdfsearch.io/img/606f3978d13d0662f8562eed2a3c8d8a.jpg) | Add to Reading ListSource URL: www.tesarobio.comLanguage: English - Date: 2015-06-03 16:42:55
|
---|
4![Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a](https://www.pdfsearch.io/img/d2ca33ad642147ed71290e6e65e92a68.jpg) | Add to Reading ListSource URL: www.gilupi.comLanguage: English - Date: 2015-07-17 05:43:05
|
---|
5![Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a](https://www.pdfsearch.io/img/a1a32669d6421a653f181602f3f1069d.jpg) | Add to Reading ListSource URL: www.gilupi.deLanguage: English - Date: 2015-03-02 07:35:26
|
---|
6![Example of a scientific poster Example of a scientific poster](https://www.pdfsearch.io/img/68cb8cdc911719c8cbf9d931a2472681.jpg) | Add to Reading ListSource URL: www.tesarobio.comLanguage: English - Date: 2013-11-07 17:55:14
|
---|
7![Example of a scientific poster Example of a scientific poster](https://www.pdfsearch.io/img/6d0448c573a3db965cf603de1e8e82f5.jpg) | Add to Reading ListSource URL: www.tesarobio.comLanguage: English - Date: 2014-11-20 16:15:48
|
---|
8![ESMOTSR-011, A Potent ALK Inhibitor with Clinical Activity in Phase I/IIa Development Glen J Weiss1, Jasgit C Sachdev2, Jeffrey R Infante3, Monica Mita4, Keith M Wilcoxen5, Vikram Kansra5, David G Brooks5, Robert ESMOTSR-011, A Potent ALK Inhibitor with Clinical Activity in Phase I/IIa Development Glen J Weiss1, Jasgit C Sachdev2, Jeffrey R Infante3, Monica Mita4, Keith M Wilcoxen5, Vikram Kansra5, David G Brooks5, Robert](https://www.pdfsearch.io/img/8754e8734e3a707492e3121aa7fa7c06.jpg) | Add to Reading ListSource URL: www.tesarobio.comLanguage: English - Date: 2013-09-27 12:02:35
|
---|
9![Drug Discovery Case History 1. Introduction Drug Discovery Case History 1. Introduction](https://www.pdfsearch.io/img/a3b2e7d5b8fca2c405bec3e6bb3af95d.jpg) | Add to Reading ListSource URL: www.brimr.orgLanguage: English - Date: 2013-07-01 10:35:04
|
---|
10![Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition](https://www.pdfsearch.io/img/0f497d844f259bfb4a0d404129acf2ea.jpg) | Add to Reading ListSource URL: www.brimr.orgLanguage: English - Date: 2012-12-23 16:51:41
|
---|